Increased Levels of sCD30 Have No Impact on the Incidence of Early ABMR and Long-Term Outcome in Intermediate-Risk Renal Transplant Patients With Preformed DSA
Background: It is still incompletely understood why some patients with preformed donor-specific anti-HLA antibodies (DSA) have reduced kidney allograft survival secondary to antibody-mediated rejection (ABMR), whereas many DSA-positive patients have favorable long-term outcomes. Elevated levels of s...
Guardado en:
Autores principales: | Thomas Drasch, Christian Bach, Markus Luber, Bernd Spriewald, Kirsten Utpatel, Maike Büttner-Herold, Bernhard Banas, Daniel Zecher |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6777b0a68ea045898933956d874c2fa9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Spot Urine Protein Excretion in the First Year Following Kidney Transplantation Associates With Allograft Rejection Phenotype at 1-Year Surveillance Biopsies: An Observational National-Cohort Study
por: Manca Oblak, et al.
Publicado: (2021) -
Antibody-Mediated Rejection and Recurrent Primary Disease: Two Main Obstacles in Abdominal Kidney, Liver, and Pancreas Transplants
por: Tsukasa Nakamura, et al.
Publicado: (2021) -
Ndufa6 regulates adipogenic differentiation via Scd1
por: Jingwei Zhang, et al.
Publicado: (2021) -
RASAL1 induces to downregulate the SCD1, leading to suppression of cell proliferation in colon cancer via LXRα/SREBP1c pathway
por: Wang,Guangchuan, et al.
Publicado: (2019) -
Influence of Persistent Inflammation in Follow-Up Biopsies After Antibody-Mediated Rejection in Kidney Transplantation
por: Gaston J. Piñeiro, et al.
Publicado: (2021)